Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heinz Weidenthaler

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
The New England Journal of Medicine|March 27, 2020
A Modified Vaccine against Smallpox. ReplyPhillip R Pittman, Heinz Weidenthaler, Paul Chaplin
Vaccine|June 5, 2024
Real-world safety data for MVA-BN: Increased frequency of syncope following intradermal administration for immunization against mpox diseaseHeinz Weidenthaler, Sanja Vidojkovic, Barbara K Martin, et al.
Vaccine|December 2, 2022
A randomized phase 3 trial to assess the immunogenicity and safety of 3 consecutively produced lots of freeze-dried MVA-BN® vaccine in healthy adultsEdgar Turner Overton, Darja Schmidt, Sanja Vidojkovic, et al.
Plos Neglected Tropical Diseases|February 11, 2022
The changing epidemiology of human monkeypox-A potential threat? A systematic reviewEveline M Bunge, Bernard Hoet, Liddy Chen, et al.
Vaccine|March 17, 2024
Safety and immunogenicity of a novel trivalent recombinant MVA-based equine encephalitis virus vaccine: A Phase 1 clinical trialCarlos Fierro, Heinz Weidenthaler, Sanja Vidojkovic, et al.
Vaccine|February 15, 2020
A randomized phase II trial to compare safety and immunogenicity of the MVA-BN smallpox vaccine at various doses in adults with a history of AIDSEdgar Turner Overton, Steven J Lawrence, Jack T Stapleton, et al.
The Journal of Infectious Diseases|April 20, 2023
Reduced Respiratory Syncytial Virus Load, Symptoms, and Infections: A Human Challenge Trial of MVA-BN-RSV VaccineElke Jordan, Golam Kabir, Stephanie Schultz, et al.
The Journal of Infectious Diseases|November 21, 2022
One- and Two-Dose Vaccinations With Modified Vaccinia Ankara-Bavarian Nordic Induce Durable B-Cell Memory Responses Comparable to Replicating Smallpox VaccinesHeiko Ilchmann, Nathaly Samy, Daniela Reichhardt, et al.
Vaccine|February 15, 2020
Safety and immunogenicity of novel modified vaccinia Ankara-vectored RSV vaccine: A randomized phase I clinical trialNathaly Samy, Daniela Reichhardt, Darja Schmidt, et al.
Human Vaccines & Immunotherapeutics|August 22, 2024
Equivalence of freeze-dried and liquid-frozen formulations of MVA-BN as smallpox and mpox vaccineRichard N Greenberg, Darja Schmidt, Daniela Reichhardt, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The New England Journal of Medicine|March 27, 2020
A Modified Vaccine against Smallpox. ReplyPhillip R Pittman, Heinz Weidenthaler, Paul Chaplin
Vaccine|June 5, 2024
Real-world safety data for MVA-BN: Increased frequency of syncope following intradermal administration for immunization against mpox diseaseHeinz Weidenthaler, Sanja Vidojkovic, Barbara K Martin, et al.
Vaccine|December 2, 2022
A randomized phase 3 trial to assess the immunogenicity and safety of 3 consecutively produced lots of freeze-dried MVA-BN® vaccine in healthy adultsEdgar Turner Overton, Darja Schmidt, Sanja Vidojkovic, et al.
Plos Neglected Tropical Diseases|February 11, 2022
The changing epidemiology of human monkeypox-A potential threat? A systematic reviewEveline M Bunge, Bernard Hoet, Liddy Chen, et al.
Vaccine|March 17, 2024
Safety and immunogenicity of a novel trivalent recombinant MVA-based equine encephalitis virus vaccine: A Phase 1 clinical trialCarlos Fierro, Heinz Weidenthaler, Sanja Vidojkovic, et al.
Vaccine|February 15, 2020
A randomized phase II trial to compare safety and immunogenicity of the MVA-BN smallpox vaccine at various doses in adults with a history of AIDSEdgar Turner Overton, Steven J Lawrence, Jack T Stapleton, et al.
The Journal of Infectious Diseases|April 20, 2023
Reduced Respiratory Syncytial Virus Load, Symptoms, and Infections: A Human Challenge Trial of MVA-BN-RSV VaccineElke Jordan, Golam Kabir, Stephanie Schultz, et al.
The Journal of Infectious Diseases|November 21, 2022
One- and Two-Dose Vaccinations With Modified Vaccinia Ankara-Bavarian Nordic Induce Durable B-Cell Memory Responses Comparable to Replicating Smallpox VaccinesHeiko Ilchmann, Nathaly Samy, Daniela Reichhardt, et al.
Vaccine|February 15, 2020
Safety and immunogenicity of novel modified vaccinia Ankara-vectored RSV vaccine: A randomized phase I clinical trialNathaly Samy, Daniela Reichhardt, Darja Schmidt, et al.
Human Vaccines & Immunotherapeutics|August 22, 2024
Equivalence of freeze-dried and liquid-frozen formulations of MVA-BN as smallpox and mpox vaccineRichard N Greenberg, Darja Schmidt, Daniela Reichhardt, et al.
Pageof 2